Ausiello Dennis A

CIK 00013819944 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001381994

Recent Transactions

50 trades

Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2026-07-08+6,500→ 6,500 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2026-07-01+7,508→ 7,508 total
Award
Rani Therapeutics Holdings, Inc.$RANI
Director Stock Option (Right to Buy)
2026-05-28+123,600→ 123,600 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2026-05-20+1,441→ 1,441 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-05-20+671→ 1,582 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$148.77/sh+4,581→ 19,645 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$189.87/sh+3,454→ 32,359 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$430.81/sh−1,985→ 30,374 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$440.54/sh−1,238→ 2,757 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$442.66/sh−641→ 911 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−3,454→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$432.94/sh−1,938→ 28,436 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−5,153→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$171.95/sh+4,032→ 28,905 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$438.34/sh−2,086→ 9,297 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−4,032→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$434.50/sh−2,098→ 26,338 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$436.00/sh−5,358→ 13,305 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$128.31/sh+5,153→ 15,064 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$151.22/sh+5,228→ 24,873 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$437.56/sh−1,922→ 11,383 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−4,581→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$439.27/sh−5,302→ 3,995 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$441.88/sh−1,205→ 1,552 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−9,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$72.01/sh+9,000→ 9,911 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-08-14$435.40/sh−7,675→ 18,663 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-08-14−5,228→ 0 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2025-07-01+6,452→ 6,452 total
Award
Rani Therapeutics Holdings, Inc.$RANI
Director Stock Option (Right to Buy)
2025-05-28+50,000→ 50,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-05-08+775→ 911 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2025-04-10+100,000→ 100,000 total
Award
Rani Therapeutics Holdings, Inc.$RANI
Stock Option (Right to Buy)
2024-12-16+15,423→ 79,317 total
Disposition to Issuer
Rani Therapeutics Holdings, Inc.$RANI
Stock Option (Right to Buy)
2024-12-16−15,423→ 0 total
Disposition to Issuer
Rani Therapeutics Holdings, Inc.$RANI
Stock Option (Right to Buy)
2024-12-16−101,276→ 0 total
Award
Rani Therapeutics Holdings, Inc.$RANI
Stock Option (Right to Buy)
2024-12-16+101,276→ 101,276 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$131.21/sh+11,250→ 11,386 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$261.63/sh−6,212→ 8,805 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$262.79/sh−4,367→ 4,438 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$263.72/sh−3,408→ 1,030 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$264.95/sh−632→ 398 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-08-06−9,000→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$259.56/sh−1,627→ 18,759 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$105.26/sh+9,000→ 20,386 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$260.40/sh−3,742→ 15,017 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2024-08-06$266.45/sh−262→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2024-08-06−11,250→ 0 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2024-07-01+64,564→ 64,564 total
Award
Rani Therapeutics Holdings, Inc.$RANI
Stock Option (Right to Buy)
2024-05-29+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O SERES THERAPEUTICS, INC. 101 CAMBRIDGE PARK DRIVE

CAMBRIDGE, MA, 02140

View on SEC.gov